Mineralys Insider Trades Show Low‑Cost Buying, High‑Price Selling & What Investors Should Watch
Mineralys Therapeutics insider trading shows strategic buying low, selling high—yet investors must weigh volatile stock, negative earnings, and pending regulatory approvals.
4 minutes to read